Transgene and BioInvent have enrolled first patient in Phase I/IIa trial of novel oncolytic virus BT-001 in solid tumors
20210301 - Transgene BT-001 FPI - EN
20210301 - Transgene BT-001 FPI - EN
20201221 - CTA Approval BT-001 - EN
20201109 Transgene BioInvent_SITC BT001_EN
Poster BT-001 M. Semmrich et al. SITC 2020 Download the [...]
20201015 - BT-001_SITC poster EN
AACR2020-BT-001 Jean-Baptiste Marchand et al. AACR 2020 Download the poster [...]